Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (361-370 of 958) with videos related to

Pageof 96
Sort By:
American Journal of Respiratory and Critical Care Medicine|April 28, 2018
Natural History over 8 Years of Pulmonary Vascular Disease in a Patient Carrying Biallelic EIF2AK4 MutationsDavid Montani, Peter Dorfmüller, Barbara Girerd, et al.
Presse Medicale (Paris, France : 1983)|January 8, 2011
Pulmonary veno-occlusive disease: the bête noire of pulmonary hypertension in connective tissue diseases?Dermot S O'Callaghan, Peter Dorfmuller, Xavier Jaïs, et al.
Chest|February 2, 2010
Characterization of pulmonary arterial hypertension patients walking more than 450 m in 6 min at diagnosisBruno Degano, Olivier Sitbon, Laurent Savale, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 13, 2014
Omalizumab in asthma: an update on recent developmentsMarc Humbert, William Busse, Nicola A Hanania, et al.
ERJ Open Research|June 3, 2026
Exploring the therapeutic potential of GLP-1 receptor agonists in pulmonary arterial hypertensionBenoit Aguado, Thomas Lacoste-Palasset, Grégoire Ruffenach, et al.
Nature Reviews. Disease Primers|January 17, 2024
Publisher Correction: Pulmonary hypertensionAna Mocumbi, Marc Humbert, Anita Saxena, et al.
Archivos De Bronconeumologia|March 1, 2020
Gas Exchange and Ventilatory Efficiency During Exercise in Pulmonary Vascular DiseasesJason Weatherald, Athénaïs Boucly, David Montani, et al.
The European Respiratory Journal|May 26, 2022
Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patientsMarc Humbert, Arnaud Bourdin, Camille Taillé, et al.
The European Respiratory Journal|March 30, 2019
Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensionMarc Humbert, Harrison W Farber, Hossein-Ardeschir Ghofrani, et al.
ERJ Open Research|June 10, 2026
Fenfluramine-associated pulmonary hypertension: a study of adverse events reporting system FAERSColine Brossat, Clément Jambon-Barbara, Alex Hlavaty, et al.
Pageof 96

Showing results (361-370 of 958) with videos related to

Sort By:
Pageof 96
American Journal of Respiratory and Critical Care Medicine|April 28, 2018
Natural History over 8 Years of Pulmonary Vascular Disease in a Patient Carrying Biallelic EIF2AK4 MutationsDavid Montani, Peter Dorfmüller, Barbara Girerd, et al.
Presse Medicale (Paris, France : 1983)|January 8, 2011
Pulmonary veno-occlusive disease: the bête noire of pulmonary hypertension in connective tissue diseases?Dermot S O'Callaghan, Peter Dorfmuller, Xavier Jaïs, et al.
Chest|February 2, 2010
Characterization of pulmonary arterial hypertension patients walking more than 450 m in 6 min at diagnosisBruno Degano, Olivier Sitbon, Laurent Savale, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 13, 2014
Omalizumab in asthma: an update on recent developmentsMarc Humbert, William Busse, Nicola A Hanania, et al.
ERJ Open Research|June 3, 2026
Exploring the therapeutic potential of GLP-1 receptor agonists in pulmonary arterial hypertensionBenoit Aguado, Thomas Lacoste-Palasset, Grégoire Ruffenach, et al.
Nature Reviews. Disease Primers|January 17, 2024
Publisher Correction: Pulmonary hypertensionAna Mocumbi, Marc Humbert, Anita Saxena, et al.
Archivos De Bronconeumologia|March 1, 2020
Gas Exchange and Ventilatory Efficiency During Exercise in Pulmonary Vascular DiseasesJason Weatherald, Athénaïs Boucly, David Montani, et al.
The European Respiratory Journal|May 26, 2022
Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patientsMarc Humbert, Arnaud Bourdin, Camille Taillé, et al.
The European Respiratory Journal|March 30, 2019
Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensionMarc Humbert, Harrison W Farber, Hossein-Ardeschir Ghofrani, et al.
ERJ Open Research|June 10, 2026
Fenfluramine-associated pulmonary hypertension: a study of adverse events reporting system FAERSColine Brossat, Clément Jambon-Barbara, Alex Hlavaty, et al.
Pageof 96